\r\n<\/a>\r\n<\/p>\n<\/div><\/section><\/div> <\/p>\n<\/div><\/section> AMSBIO has launched a comprehensive kit containing all variants of their recombinant laminin E8 fragments, designed to support researchers working with embryonic stem (ES) and induced pluripotent stem (iPS) cells. The iMatrix Palette aims to streamline protocol development for cell culture and differentiation applications.<\/strong><\/p>\n <\/p>\n When culturing human stem cells under feeder-free conditions, extracellular matrix (ECM) proteins are essential for cellular adherence to culture vessels. The iMatrix The kit\u2019s multiple laminin isoforms have been developed to facilitate differentiation across all three primary germ layers: ectoderm, mesoderm and endoderm. By providing researchers with access to the complete range of variants in a single package, the system enables systematic evaluation and selection of optimal conditions for specific experimental requirements.<\/p>\n The fragments can be utilised via both pre-mixing and pre-coating protocols, offering methodological flexibility. This versatility, combined with the comprehensive nature of the kit, may help laboratories avoid purchasing multiple individual variants, potentially offering cost efficiencies whilst maintaining experimental reproducibility.<\/p>\n The consolidated format is intended to support efficient protocol optimisation, particularly in laboratories developing novel differentiation procedures or refining existing methods. The manufacturers suggest that access to all variants simultaneously may enhance experimental accuracy and reproducibility by enabling direct comparative studies under standardised conditions.<\/p>\n For additional technical information, visit: https:\/\/www.amsbio.com\/imatrix-recombinant-laminin-series<\/a> <\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":" AMSBIO has launched a comprehensive kit containing all variants of their recombinant laminin E8 fragments, designed to support researchers working with embryonic stem (ES) and induced pluripotent stem (iPS) cells. The iMatrix Palette aims to streamline protocol development for cell culture and differentiation applications.<\/p>\n","protected":false},"author":3,"featured_media":22435,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-22552","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/22552"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=22552"}],"version-history":[{"count":1,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/22552\/revisions"}],"predecessor-version":[{"id":22553,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/22552\/revisions\/22553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/22435"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=22552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=22552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=22552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nLaminin fragment kit from AMSBIO aims to enhance stem cell culture efficiency<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\nProtocol development challenges<\/h4>\n
\nE8 fragments represent a significant advancement over traditional full-length laminin solutions, comprising just 20% of the complete protein whilst retaining all integrin binding sites. This structural optimisation reportedly enables enhanced cell adhesion and expansion characteristics.<\/p>\nDifferentiation pathway support<\/h4>\n
Flexible application methods<\/h4>\n
\nDigital issue: Please click here<\/a> for more information<\/p>\n<\/div><\/section>
\n
\n
\nShare this<\/h5>